CY1117566T1 - Αγωγη νευροεκφυλιστικων νοσηματων με πορφυρινη - Google Patents

Αγωγη νευροεκφυλιστικων νοσηματων με πορφυρινη

Info

Publication number
CY1117566T1
CY1117566T1 CY20161100471T CY161100471T CY1117566T1 CY 1117566 T1 CY1117566 T1 CY 1117566T1 CY 20161100471 T CY20161100471 T CY 20161100471T CY 161100471 T CY161100471 T CY 161100471T CY 1117566 T1 CY1117566 T1 CY 1117566T1
Authority
CY
Cyprus
Prior art keywords
neurocological
porphyrine
diseases
treatment
compositions
Prior art date
Application number
CY20161100471T
Other languages
English (en)
Inventor
Manisha Patel
Brian Day
John Mcmanus
Original Assignee
Aeolus Sciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP11831640.5A external-priority patent/EP2625180B1/en
Application filed by Aeolus Sciences, Inc. filed Critical Aeolus Sciences, Inc.
Publication of CY1117566T1 publication Critical patent/CY1117566T1/el

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Αποκαλύπτονται στην παρούσα συνθέσεις και μέθοδοι αγωγής μιας νευροεκφυλιστικής διαταραχής.
CY20161100471T 2010-10-06 2016-05-30 Αγωγη νευροεκφυλιστικων νοσηματων με πορφυρινη CY1117566T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39027010A 2010-10-06 2010-10-06
EP11831640.5A EP2625180B1 (en) 2010-10-06 2011-10-06 Porphyrin treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
CY1117566T1 true CY1117566T1 (el) 2017-04-26

Family

ID=58606692

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161100471T CY1117566T1 (el) 2010-10-06 2016-05-30 Αγωγη νευροεκφυλιστικων νοσηματων με πορφυρινη

Country Status (1)

Country Link
CY (1) CY1117566T1 (el)

Similar Documents

Publication Publication Date Title
CY1121862T1 (el) Αντισωματα anti-phf-tau και χρησεις αυτων
CY1121182T1 (el) Συνθεσεις χρησιμες για τη θεραπεια διαταραχων που σχετιζονται με kit
CY1121653T1 (el) C1-inh συνθεσεις και μεθοδοι για την προληψη και αγωγη διαταραχων συνδεομενων με ανεπαρκεια αναστολεα c1 εστερασης
BR112018010464A8 (pt) formulações farmacêuticas tópicas para tratar condições inflamatórias relacionadas
MX2016003129A (es) Terapia de combinacion de anticuerpos contra el csf-1r humano y anticuerpos contralel pd-l1 humano.
BR112015019995A2 (pt) Combinação terapêutica envolvendo anticorpos contra claudina 18.2 para tratamento de câncer
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
BR112015002864A2 (pt) conjunto de cateter e método de fornecer o conjunto de cateter.
BR112013002012A2 (pt) métodos e composições para terapia de câncer de fígado
BR112014021104A2 (pt) métodos e composições para o tratamento da doença de huntington
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
UY34721A (es) Anticuerpos anti-hla-b*27 y usos de éstos.
UA110813C2 (uk) Лікування ліподистрофії
BR112015001838A2 (pt) composições de inibidor de efluxo e métodos de tratamento utilizando o mesmo.
IN2014DN00288A (el)
IN2014DN00286A (el)
IN2014MN00093A (el)
IN2014MN01378A (el)
IN2014DN06792A (el)
CY1120877T1 (el) Συνθεσεις και μεθοδοι για την αντιμετωπιση της κοιλιοκακης
IN2014DN05885A (el)
BR112013031117A2 (pt) scilo-inositol para o tratamento de transtornos comportamentais e psiquiátricos.
MX2015010077A (es) Terapia de combinacion para el tratamiento de neumonia nosocomial.
ECSP14011792A (es) Inhibidores de iap
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями